Stem Cells Lab

STEM CELL MARKET
IN 2021 AND BEYOND

Regenerative Medicine, Stem Cells, and Cellular Therapies in general continues to rally worldwide recognition, more in the current times as governments fund research and expand access to this technology.

These once-controversial treatments are fast becoming one of medicine’s most exciting technologies.
From several FDA-approved treatments to numerous clinical studies currently underway by companies and physicians around the world are generating truly remarkable results.
Government and private funding are the main driving force behind the exponential growth of stem cell therapies. Robust and accelerated research has led to significant advances in all types of regenerative biologics, with stem cell technology at the forefront.

CELL THERAPY:

Transplantation of engineered human cells for therapeutic applications.

TISSUE ENGINEERING:

Ex vivo growth of tissue/organs from progenitor cells using bio-scaffonlds to reconstruct a part of the while organ with natural functions.

SMALL MOLECULES:

Small cells or biologic agents that simulate dormant or endogenous cells to recover regenerative properties.

GENE THERAPY:

A method to introduce genetic materials (DNA, siRNA, mRNA) in cells to compensate for aberrant genes or to induce protein expression.

TARGET MARKET AND SIZE

Global Stem Cells Group has identified a clear and substantial target market. The Company will target physicians as referral sources worldwide. The Company will also target patients worldwide and especially the US.

STEM CELL THERAPY MARKET

The market is expected to experience exponential growth in stem cell procedures. The demand of patients to receive the benefits of stem cell procedures will increase correspondingly.

STEM CELL THERAPY MARKET

The market is expected to experience exponential growth in stem cell procedures. The demand of patients to receive the benefits of stem cell procedures will increase correspondingly.

Menu